S. Mori
Molecular Biology · with Huang · 2014
A researcher in the Science corpus: 1 paper; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 29 citations into it
- Oncology — 27 citations into it
- Cancer Research — 17 citations into it
- Pulmonary and Respiratory Medicine — 6 citations into it
Whom S. Mori trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from S. Mori's perspective
Ordered by how strongly the researchers S. Mori trusts endorse each paper. Same corpus, a different order for every researcher.
- Epithelial–mesenchymal transitions in tumour progression (Nature Reviews. Cancer)
- Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers (Nature Medicine)
- Tumor Metastasis: Molecular Insights and Evolving Paradigms (Cell)
- Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. (Cancer Research)
- Epithelial-mesenchymal transitions in development and disease. (Cell)
- affy - analysis of Affymetrix GeneChip data at the probe level (Bioinform.)
- Adjusting batch effects in microarray expression data using empirical Bayes methods. (Biostatistics)
- Systematic identification of genomic markers of drug sensitivity in cancer cells (Nature)
- Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. (Journal of Clinical Oncology)
- An epithelial-mesenchymal transition (EMT) gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance (Clinical Cancer Research)